Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 680

1.

Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.

Takagi K, Ielasi A, Shannon J, Latib A, Godino C, Davidavicius G, Mussardo M, Ferrarello S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):491-8. doi: 10.1161/CIRCINTERVENTIONS.111.964874. Epub 2012 Jul 31.

2.

Immediate results and long-term clinical outcome of patients with unprotected distal left main restenosis: the CORPAL registry (Córdoba and Las Palmas).

Ojeda S, Pan M, Martín P, Mazuelos F, Suárez de Lezo J, Romero M, Segura J, Pavlovic D, Medina A, Suárez de Lezo J.

JACC Cardiovasc Interv. 2014 Feb;7(2):212-21. doi: 10.1016/j.jcin.2013.06.017. Epub 2014 Jan 15.

3.

Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.

4.

Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.

Luo Y, Yu X, Chen F, Du X, He J, Gao Y, Zhang X, Zhang Y, Ren X, Lv S, Ma C.

Coron Artery Dis. 2012 Aug;23(5):322-9. doi: 10.1097/MCA.0b013e3283564961.

PMID:
22750912
5.

Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A; ISAR-LEFT MAIN Study Investigators.

JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.

6.

Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.

Abdel-Wahab M, Nienaber CA, Mostafa AE, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck KH, Hamm C, Richardt G; German Drug-Eluting Stent (DES.DE) registry.

EuroIntervention. 2011 Jun;7(2):201-8. doi: 10.4244/EIJV7I2A34.

7.

Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.

Simard T, Hibbert B, Chong AY, Ruchin P, Le May M, Labinaz M, Froeschl M, So D, Glover C, Marquis JF, O'Brien E.

Catheter Cardiovasc Interv. 2012 Aug 1;80(2):E15-22. doi: 10.1002/ccd.23244. Epub 2012 Jan 10.

PMID:
21805580
8.

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.

J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.

9.

First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.

Naganuma T, Chieffo A, Takagi K, Panoulas VF, Mitomo S, Sticchi A, Latib A, Miyazaki T, Sato K, Costopoulos C, Fujino Y, Montorfano M, Carlino M, Nakamura S, Colombo A.

Catheter Cardiovasc Interv. 2015 Feb 15;85(3):E63-9. doi: 10.1002/ccd.25624. Epub 2014 Aug 20.

PMID:
25099758
10.

Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis.

Liistro F, Fineschi M, Grotti S, Angioli P, Carrera A, Ducci K, Gori T, Falsini G, Pierli C, Bolognese L.

EuroIntervention. 2009 Sep;5(4):454-9.

PMID:
19755333
11.

Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.

Chen SL, Xu B, Mintz G, Ye F, Zhang JJ, Kan J, Sun XW, Zhang AP, Chen JG, Qian J, Kwan TW.

Chin Med J (Engl). 2010 Apr 5;123(7):794-9.

PMID:
20497666
12.

The impact of main branch restenosis on long term mortality following drug-eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: the Milan and New-Tokyo (MITO) Registry.

Takagi K, Ielasi A, Basavarajaiah S, Chieffo A, Shannon J, Godino C, Hasegawa T, Naganuma T, Fujino Y, Latib A, Carlino M, Montorfano M, Nakamura S, Colombo A.

Catheter Cardiovasc Interv. 2014 Sep 1;84(3):341-8. doi: 10.1002/ccd.25178. Epub 2014 Apr 30.

PMID:
24038911
13.

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.

Nojima Y, Yasuoka Y, Kume K, Adachi H, Hattori S, Matsutera R, Kohama Y, Sasaki T.

Coron Artery Dis. 2014 Dec;25(8):638-44. doi: 10.1097/MCA.0000000000000159.

14.

Long-term outcome of percutaneous coronary intervention for unprotected left main coronary artery disease.

Wu XM, Liu CP, Lin WC, Kao HL.

Int J Cardiol. 2010 Feb 4;138(3):272-6. doi: 10.1016/j.ijcard.2008.08.016. Epub 2008 Sep 19.

PMID:
18804295
15.

Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).

Rittger H, Waliszewski M, Brachmann J, Hohenforst-Schmidt W, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Schlundt C, Zimmermann S, Lonke S, von Cranach M, Markovic S, Daniel WG, Achenbach S, Wöhrle J.

JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.

16.

Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

JACC Cardiovasc Interv. 2012 Jul;5(7):718-27. doi: 10.1016/j.jcin.2012.03.022.

17.

Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.

Ielasi A, Takagi K, Latib A, Basavarajaiah S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.

Catheter Cardiovasc Interv. 2014 Mar 1;83(4):530-8. doi: 10.1002/ccd.25174. Epub 2013 Sep 30.

PMID:
23983065
18.

Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.

Ota H, Mahmoudi M, Kitabata H, Torguson R, Chen F, Satler LF, Suddath WO, Pichard AD, Waksman R.

Cardiovasc Revasc Med. 2015 Mar;16(2):84-9. doi: 10.1016/j.carrev.2015.01.004. Epub 2015 Jan 29.

PMID:
25870152
19.

Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.

Lee JM, Park J, Kang J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS.

JACC Cardiovasc Interv. 2015 Mar;8(3):382-94. doi: 10.1016/j.jcin.2014.09.023. Epub 2015 Feb 18.

20.

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.

Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ; Melbourne Interventional Group Investigators.

Int J Cardiol. 2008 Nov 28;130(3):374-9. doi: 10.1016/j.ijcard.2008.06.046. Epub 2008 Aug 15.

PMID:
18706719

Supplemental Content

Support Center